What move does the options market price into Puma Biotechnology's report?

Implied ±16.4%, either direction.

How often does Puma Biotechnology move more than the options market prices?

3 of the last 8 reports moved at least as far as the implied move.

PBYINasdaqPharmaceutical Preparations

Puma Biotechnology, Inc. (PBYI) earnings date, market-implied expected move, and options open interest by expiry

10.42

pre 10.25 +0.29%

Pre-market07:00 ETdelayed

Open10.25Volume406,502Mkt cap$527.6MP/E19.34EPS0.53

Day10.25 – 10.2550%52-wk4.58 – 11.5082%

PBYI

Puma Biotechnology, Inc.

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±16.4%implied · straddle

8.5411.90

spot 10.22exp Nov 20ATM strike 10ATM straddle 1.97IV 113%

Nov 3 close

Expected move

Inputs

Next report

Nov 5

after close · in 1 day

est.Q3 FY26

Calendar

Next report

Last report

+9.73%

vs ±45.0% implied · ×0.22

shaded = implied · ▲▼ = realized

Aug 6 '26 · confirmed

Implied vs realized

Linked news

50mCVS · customerCVS Health posts net income of $2,172 million in Q3; $8,094 million YTD
15hPFE · supplierPfizer names Cecile Guegan CFO; $1,300,000 base, $1,300,000 target incentive

News

Largest filed tie

13F top-10 QoQ

+7.03%

shares held · 10 largest managers

13F · Jun 30 '26127d lag

161 managers

Top fund weight

0.01%

PBYI weight · IWM

N-PORTJun 30 '26

3 funds

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

Puma Biotechnology (PBYI) is expected to report on Nov 5 after close (estimated date).

Implied vs realized

8 reports

3 of 8≥ implied

avg implied: ±34.0%
avg realized: ±12.8%

Nov 7 '24Nov 7 '24confirmed±82.7%▼−4.95%×0.06

Feb 27 '25Feb 27 '25confirmed±13.3%▲+19.73%×1.49

May 8 '25May 8 '25confirmed±17.0%▼−5.21%×0.31

Aug 7 '25Aug 7 '25confirmed±31.9%▲+12.16%×0.38

Q3 FY25Nov 6 '25confirmed±18.4%▲+22.24%×1.21

Q1 FY26Feb 26 '26confirmed±21.7%▼−25.00%×1.15

May 7 '26May 7 '26confirmed±42.0%▲+3.17%×0.08

Q2 FY26Aug 6 '26confirmed±45.0%▲+9.73%×0.22

quarterimplied−85%0+85%realized×

Q2 FY26±45.0%▲+9.73%×0.22

May '26±42.0%▲+3.17%×0.08

Q1 FY26±21.7%▼−25.00%×1.15

Q3 FY25±18.4%▲+22.24%×1.21

Aug '25±31.9%▲+12.16%×0.38

May '25±17.0%▼−5.21%×0.31

2 older reports

Feb '25±13.3%▲+19.73%×1.49

Nov '24±82.7%▼−4.95%×0.06

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 3 expiries · Oct 23 close

0.03OI · 3 expiries · Oct 23 closeP/C open interest · Nov 20 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

30+25%Nov 2016d1,014+2%

2400%Dec 1844d0.47516+7%0.47

15+67%Mar 19135d0.03438+2%0.03

ExpiryPutsCallsP/C

Nov 2016d30+25%1,014+2%0.03

Dec 1844d2400%516+7%0.47

Mar 19135d15+67%438+2%0.03

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±16.4%

Funds 3

IWM±0.0%

UWM±0.0%

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

as filedQ2 FY26

14.49%as filednet margin · revenue +26.08% QoQ · +7.75% YoY

Revenue

$57M+26.08% QoQ

Gross profit

$44M+28.02% QoQ

77.92% margin

Operating income

$8M+298.15% QoQ

13.42% margin

Pre-tax income

$8M+340.59% QoQ

Net income

$8M+318.20% QoQ

14.49% margin

Cost of revenue

$12M+19.68% QoQ

Operating expenses

$36M−4.65% QoQ

R&D $19M

SG&A $18M

Tax

$56,000−82.82% QoQ

Other income

$660,000+64.59% QoQ

Revenue$57M+26.08%

Gross profit

$44M+28.02%

77.92% margin

Operating income

$8M+298.15%

13.42% margin

Pre-tax income

$8M+340.59%

Net income

$8M+318.20%

14.49% margin

Cost of revenue

$12M+19.68%

Operating expenses

$36M−4.65%

R&D $19M

SG&A $18M

Other income$660,000+64.59%

Tax$56,000−82.82%

flow · deduction · inflow · signed % = QoQSource: SEC filings · standardized · QE Jun 30 '26 · width = $

Revenue flow

Intraday

No trades yet today.

Intraday

Event sensitivity

PPI ×1.34· ±4.0% vs ±3.0% · 10 releases

eventrelease day|move|up · n×base

PPIproducer prices±4.0%6 of 10×1.34

NFPjobs report±2.9%6 of 10×0.96

FOMCrate decision±2.8%10 of 24×0.93

PCEpersonal income & outlays±2.6%11 of 19×0.88

GDPgross domestic product±1.6%10 of 19×0.53

CPROFcorporate profits±1.4%5 of 12×0.48

CPIconsumer prices±0.9%4 of 10×0.29

Bar = avg |move| to ±5% · tick = ±3.0% avg day · ×base = |move| ÷ ±3.0% · min 6 releases

Earnings history

EPS 0.16 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 6 '26 · confirmed	0.16	—
Q1 FY26	Feb 26 '26 · confirmed	-0.07	—
Q3 FY25	Nov 6 '25 · confirmed	0.17	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod